董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Jeffrey Busch | 男 | Chairman of the Board, Chief Executive Officer and President,Director | 60 | 59.67万美元 | 未持股 | 2020-07-24 |
| Zhang Jingguo | 男 | Director | 56 | 未披露 | 未持股 | 2020-07-24 |
| Ronald Marston | 男 | Director | 77 | 10.55万美元 | 未持股 | 2020-07-24 |
| Henry Cole | 男 | Director | 75 | 11.48万美元 | 未持股 | 2020-07-24 |
| Roscoe Moore | 男 | Director | 75 | 9.19万美元 | 未持股 | 2020-07-24 |
| Matthew L. Cypher | 男 | Director | 43 | 10.49万美元 | 未持股 | 2020-07-24 |
| Zhang Huiqi | 女 | Director | 30 | 2.40万美元 | 未持股 | 2020-07-24 |
| Paula Crowley | 女 | Director | 65 | 9.68万美元 | 未持股 | 2020-07-24 |
| Lori Wittman | 女 | Director | 61 | 10.39万美元 | 未持股 | 2020-07-24 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Jeffrey Busch | 男 | Chairman of the Board, Chief Executive Officer and President,Director | 60 | 59.67万美元 | 未持股 | 2020-07-24 |
| Alfonzo Leon | 男 | Chief Investment Officer | 44 | 45.63万美元 | 未持股 | 2020-07-24 |
| Danica Holley | 女 | Chief Operating Officer | 47 | 未披露 | 未持股 | 2020-07-24 |
| Allen Webb | 男 | Senior Vice President, SEC Reporting and Technical Accounting | 52 | 31.46万美元 | 未持股 | 2020-07-24 |
| Robert Kiernan | 男 | Chief Financial Officer and Treasurer | 54 | 37.70万美元 | 未持股 | 2020-07-24 |
| Jamie Barber | 男 | General Counsel and Secretary | 43 | 33.22万美元 | 未持股 | 2020-07-24 |
董事简历
中英对照 |  中文 |  英文- Jeffrey Busch
-
Jeffrey Busch, 2014年9月起担任董事。Busch先生自1985年以来一直是房地产行业的积极投资者。Busch先生自2015年8月起担任公司董事长兼总裁,自2017年8月起担任公司首席执行官。他的经验包括开发各种资产类别的众多物业,拥有和管理几个州的房地产,包括租赁住房和各种各样的商业房地产。2001年以来,他还担任Safe Blood International Foundation的总裁,在那里他监督35个发展中国家的医疗设施的建立,由CDC和USAID、埃克森美孚和盖茨基金会资助。布什曾在两届总统政府中被任命为总统,一次是在住房和城市事务部(Department of Housing and Urban Affairs),另一次是在日内瓦的联合国(United Nations)担任美国代表。在本代理声明的“薪酬、讨论和分析”部分讨论我们的内部化之前,Busch先生担任Inter-American Management LLC的总裁,我们的前外部顾问(“IAM”)或我们的“前顾问”,以及自2013年以来的董事,并且是IAM的母公司Inter-American Group Holdings Inc.(“IAGH”)的15股已发行普通股的所有者。自2014年10月以来,Busch先生一直担任American Housing REIT Inc.(以前由IAM管理)的董事会主席。Busch先生曾担任American Pacific Bankcorp, Inc. (APB)的董事至2020年2月。Busch先生还担任癌症诊断公司Avant Diagnostics, Inc. (AVDX)的董事会主席,以及OncBioMune Pharmaceuticals, Inc.(专门从事创新癌症治疗疗法的生物技术公司)的董事会主席。他持有纽约大学斯特恩商学院的学士学位、纽约大学公共管理硕士学位和埃默里大学的法学博士学位。
Jeffrey Busch,Director since September 2014. Mr. Busch has been an active investor in the real estate industry since 1985. Mr. Busch also has served as Chairman and President of Company from August 2015 to present and has served as Chief Executive Officer of Company since August 2017. His experience includes developing numerous properties in various asset classes, owning and managing real estate in several states, including rental housing, and a wide variety of commercial real estate. Since 2001 Mr. Busch has also served as President of Safe Blood International Foundation, where he oversees the establishment of medical facilities in 35 developing nations, funded by the CDC and USAID, Exxon Mobil,and the Gates Foundation. Mr. Busch has had presidential appointments in two presidential administrations, one in the Department of Housing and Urban Affairs and the other at the United Nations in Geneva, where he served as a United States delegate. Prior to Internalization which is discussed in the "Compensation, Discussion and Analysis" section of this Proxy Statement, Mr. Busch served as President of Inter-American Management LLC, former external advisor ("IAM") or "Former Advisor", as well as a Director since 2013 and was an owner of 15 of the outstanding common stock of Inter-American Group Holdings Inc. ("IAGH"), the parent company of IAM. Since October 2014 Mr. Busch has served as Chairman of the Board of American Housing REIT Inc., which was formerly managed by IAM. Mr. Busch served as a director of American Pacific Bankcorp, Inc. (APB) through February 2020. Mr. Busch also serves as the Chairman of the Board of Directors of Avant Diagnostics, Inc. (AVDX), a cancer diagnostics company, and the Chairman of the Board of Directors of OncBioMune Pharmaceuticals, Inc., a biotechnology company specializing in innovative cancer treatment therapies. Mr. Busch holds a B.A. from New York University in the Stern School of Business, a Masters of Public Administration from New York University, and a J.D. from Emory University. - Jeffrey Busch, 2014年9月起担任董事。Busch先生自1985年以来一直是房地产行业的积极投资者。Busch先生自2015年8月起担任公司董事长兼总裁,自2017年8月起担任公司首席执行官。他的经验包括开发各种资产类别的众多物业,拥有和管理几个州的房地产,包括租赁住房和各种各样的商业房地产。2001年以来,他还担任Safe Blood International Foundation的总裁,在那里他监督35个发展中国家的医疗设施的建立,由CDC和USAID、埃克森美孚和盖茨基金会资助。布什曾在两届总统政府中被任命为总统,一次是在住房和城市事务部(Department of Housing and Urban Affairs),另一次是在日内瓦的联合国(United Nations)担任美国代表。在本代理声明的“薪酬、讨论和分析”部分讨论我们的内部化之前,Busch先生担任Inter-American Management LLC的总裁,我们的前外部顾问(“IAM”)或我们的“前顾问”,以及自2013年以来的董事,并且是IAM的母公司Inter-American Group Holdings Inc.(“IAGH”)的15股已发行普通股的所有者。自2014年10月以来,Busch先生一直担任American Housing REIT Inc.(以前由IAM管理)的董事会主席。Busch先生曾担任American Pacific Bankcorp, Inc. (APB)的董事至2020年2月。Busch先生还担任癌症诊断公司Avant Diagnostics, Inc. (AVDX)的董事会主席,以及OncBioMune Pharmaceuticals, Inc.(专门从事创新癌症治疗疗法的生物技术公司)的董事会主席。他持有纽约大学斯特恩商学院的学士学位、纽约大学公共管理硕士学位和埃默里大学的法学博士学位。
- Jeffrey Busch,Director since September 2014. Mr. Busch has been an active investor in the real estate industry since 1985. Mr. Busch also has served as Chairman and President of Company from August 2015 to present and has served as Chief Executive Officer of Company since August 2017. His experience includes developing numerous properties in various asset classes, owning and managing real estate in several states, including rental housing, and a wide variety of commercial real estate. Since 2001 Mr. Busch has also served as President of Safe Blood International Foundation, where he oversees the establishment of medical facilities in 35 developing nations, funded by the CDC and USAID, Exxon Mobil,and the Gates Foundation. Mr. Busch has had presidential appointments in two presidential administrations, one in the Department of Housing and Urban Affairs and the other at the United Nations in Geneva, where he served as a United States delegate. Prior to Internalization which is discussed in the "Compensation, Discussion and Analysis" section of this Proxy Statement, Mr. Busch served as President of Inter-American Management LLC, former external advisor ("IAM") or "Former Advisor", as well as a Director since 2013 and was an owner of 15 of the outstanding common stock of Inter-American Group Holdings Inc. ("IAGH"), the parent company of IAM. Since October 2014 Mr. Busch has served as Chairman of the Board of American Housing REIT Inc., which was formerly managed by IAM. Mr. Busch served as a director of American Pacific Bankcorp, Inc. (APB) through February 2020. Mr. Busch also serves as the Chairman of the Board of Directors of Avant Diagnostics, Inc. (AVDX), a cancer diagnostics company, and the Chairman of the Board of Directors of OncBioMune Pharmaceuticals, Inc., a biotechnology company specializing in innovative cancer treatment therapies. Mr. Busch holds a B.A. from New York University in the Stern School of Business, a Masters of Public Administration from New York University, and a J.D. from Emory University.
- Zhang Jingguo
-
Zhang Jingguo,2010年3月至今,他目前担任Henan Real Estate Chamber of Commerce的总裁。2012年7月至今,他担任Industry & Commerce Association of the Henan Province副总裁。他是Zhengzhou University的毕业生导师。
Zhang Jingguo,Director since August 2015. Mr. Zhang has approximately 20 years of experience in real estate development in China. Mr. Zhang currently serves as the Chairman, Chief Executive Officer and Executive Director of Zensun Enterprises Limited formerly ZH International Holdings, Ltd, which is a beneficial owner of more than five percent of the outstanding shares of our common stock and, prior to the Internalization, holder of 85 of the outstanding shares of common stock of IAGH. From 2015 until the Internalization, Mr. Zhang also was a director of IAGH. Mr. Zhang is currently a Non-Executive Director of Bank of Zhengzhou Co. Ltd., whose shares are listed on the Shenzhen Stock Exchange (Stock Code:002936) and on the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code:6196), and an Executive Director and the Chairman of Zanyu Technology Group Co. Ltd., a listed company on the Shenzhen Stock Exchange (Stock Code:002637). He also serves as Senior Consultant of Henan Real Estate Chamber of Commerce (October 2016 until present), Vice-President of Industry & Commerce Association of the Henan Province (July 2012 until present), as a graduate tutor of Zhengzhou University (May 2011 until present) and as a member of the Henan Provincial Committee of Chinese People’s Political Consultative Conference (2012 until present). From 1995 to 2001 he worked at Xingye Real Estate as general manager, where he was responsible for its overall operations. Mr. Zhang co-founded Henan Zensun Real Estate Co., Ltd., one of the top 100 property development companies in China. From 1983 to 1995 Mr. Zhang held various positions at the then Light Industry Bureau of Henan Province, the governmental authority in charge of the light industry in the Henan Province and its associated collectively-owned enterprises. During the years of 2015 2016 and 2017 Mr. Zhang was named “Outstanding Real Estate Developer of Henan Province” by Real Estate Association of Henan Province. Mr. Zhang is the father of Zhang Huiqi.Mr. Zhang received a Bachelor’s degree in physics from Zhengzhou University in July 1983 and an Executive MBA degree from Guanghua School of Management, Peking University in July 2013. Mr. Zhang received his senior engineer qualification from the People’s Government of Henan Province. In May 2012 he received his first-class construction engineer qualification from the Ministry of Housing and Urban-Rural Development. Mr. Zhang is also currently a delegate of the 13th Henan Provincial People’s Congress (January 2018 until present). - Zhang Jingguo,2010年3月至今,他目前担任Henan Real Estate Chamber of Commerce的总裁。2012年7月至今,他担任Industry & Commerce Association of the Henan Province副总裁。他是Zhengzhou University的毕业生导师。
- Zhang Jingguo,Director since August 2015. Mr. Zhang has approximately 20 years of experience in real estate development in China. Mr. Zhang currently serves as the Chairman, Chief Executive Officer and Executive Director of Zensun Enterprises Limited formerly ZH International Holdings, Ltd, which is a beneficial owner of more than five percent of the outstanding shares of our common stock and, prior to the Internalization, holder of 85 of the outstanding shares of common stock of IAGH. From 2015 until the Internalization, Mr. Zhang also was a director of IAGH. Mr. Zhang is currently a Non-Executive Director of Bank of Zhengzhou Co. Ltd., whose shares are listed on the Shenzhen Stock Exchange (Stock Code:002936) and on the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code:6196), and an Executive Director and the Chairman of Zanyu Technology Group Co. Ltd., a listed company on the Shenzhen Stock Exchange (Stock Code:002637). He also serves as Senior Consultant of Henan Real Estate Chamber of Commerce (October 2016 until present), Vice-President of Industry & Commerce Association of the Henan Province (July 2012 until present), as a graduate tutor of Zhengzhou University (May 2011 until present) and as a member of the Henan Provincial Committee of Chinese People’s Political Consultative Conference (2012 until present). From 1995 to 2001 he worked at Xingye Real Estate as general manager, where he was responsible for its overall operations. Mr. Zhang co-founded Henan Zensun Real Estate Co., Ltd., one of the top 100 property development companies in China. From 1983 to 1995 Mr. Zhang held various positions at the then Light Industry Bureau of Henan Province, the governmental authority in charge of the light industry in the Henan Province and its associated collectively-owned enterprises. During the years of 2015 2016 and 2017 Mr. Zhang was named “Outstanding Real Estate Developer of Henan Province” by Real Estate Association of Henan Province. Mr. Zhang is the father of Zhang Huiqi.Mr. Zhang received a Bachelor’s degree in physics from Zhengzhou University in July 1983 and an Executive MBA degree from Guanghua School of Management, Peking University in July 2013. Mr. Zhang received his senior engineer qualification from the People’s Government of Henan Province. In May 2012 he received his first-class construction engineer qualification from the Ministry of Housing and Urban-Rural Development. Mr. Zhang is also currently a delegate of the 13th Henan Provincial People’s Congress (January 2018 until present).
- Ronald Marston
-
Ronald Marston,他加入HCA International现Health Care Corporation of America(Hospital Corporation of America的子公司)。他担任其职务知道1990年。在建立英国伦敦办公司之后1974年,他回到公司总部。1979年1月他担任财务和行政副总裁。1980年7月他在此回到伦敦。1981年他担任HCA International, Ltd.的总裁。1987年他担任 HCA International Company的首席执行官,负责国际上所有的开发和运营。在他的领导下,HCA International Company成长为在英国拥有10个医院和7个疗养院;10家澳大利亚医院;中美洲和南美洲5医院和55诊;重组1650床新加坡总医院(Singapore General Hospital)的管理合同;沙特利雅得the King Fahad National Guard Hospital(第一个非美国军事医院,是JCAH认可美国以外的国家)的调试和管理合同和沙特阿拉伯王国最长的聘任合同。1989年Hospital Corporation of America该公司私有化后,公司将国际公司出售给几个买家。出售之后,他和他的管理团队收到某些资产收购和管理合同。他成为私人控股公司的创始人、董事长和首席执行官。加入Vanderbilt之前,他负责 Twelfth Evacuation Hospital(越南古芝县)400各床位的培训和管理。他获得Tennessee Technological University的学士学位,医疗管理学院卫生服务证书和California Western University管理学博士学位。
Ronald Marston,Director since August 2015. Mr. Marston has more than 40 years of experience in international healthcare and is known as an international authority on healthcare systems and trends. In 1973 Mr. Marston joined HCA International now Health Care Corporation of America, a subsidiary of Hospital Corporation of America and was employed there through 1990. In 1980 he was promoted to CEO & Chairman HCA United Kingdom. In 1987 he was promoted to President and CEO of HCA International with responsibility for all development and operations internationally. Under Mr. Marston’s leadership, HCA International grew to include 10 hospitals and seven nursing homes in the United Kingdom; 10 hospitals in Australia; five hospitals and 55 clinics in Central and South America; a management contract for the restructuring of the Singapore General Hospital; a commissioning and management contract for the King Fahad National Guard Hospital in Riyadh, Saudi Arabia; and the longest standing recruitment contract in Saudi Arabia. Hospital Corporation of America sold HCA International in 1989 after the company elected to go private. After the sale, Mr. Marston and his management team acquired certain assets and management contracts and he became the founder, Chairman, and CEO of the resulting privately held company, Health Care Corporation of America, doing business as HCCA International, where he was CEO and President, positions he held until 2010. He sold his interest in HCCA International in 2010 and then started two companies of his own, Southern Manor Living Centers LLC and HCCA Management Company. Mr. Marston was the founder and served as CEO of Southern Manor Living Centers LLC, three assisted living facilities in Tennessee (which he sold in November 2019), and HCCA Management Company, where he is Founder and CEO doing business in the international healthcare industry.Mr. Marston’s previous experience was with Vanderbilt University Medical Center from 1968 to 1973. Prior to joining Vanderbilt, he was responsible for the training and administration of the 400 bed, Twelfth Evacuation Hospital located in Cu Chi, Republic of Vietnam and a graduate of the airborne school in Fort Benning, GA. Mr. Marston holds a B.A. from Tennessee Technological University; a Certificate in Healthcare Administration from the Academy of Health Service; and a Ph.D. in Management from California Western University. - Ronald Marston,他加入HCA International现Health Care Corporation of America(Hospital Corporation of America的子公司)。他担任其职务知道1990年。在建立英国伦敦办公司之后1974年,他回到公司总部。1979年1月他担任财务和行政副总裁。1980年7月他在此回到伦敦。1981年他担任HCA International, Ltd.的总裁。1987年他担任 HCA International Company的首席执行官,负责国际上所有的开发和运营。在他的领导下,HCA International Company成长为在英国拥有10个医院和7个疗养院;10家澳大利亚医院;中美洲和南美洲5医院和55诊;重组1650床新加坡总医院(Singapore General Hospital)的管理合同;沙特利雅得the King Fahad National Guard Hospital(第一个非美国军事医院,是JCAH认可美国以外的国家)的调试和管理合同和沙特阿拉伯王国最长的聘任合同。1989年Hospital Corporation of America该公司私有化后,公司将国际公司出售给几个买家。出售之后,他和他的管理团队收到某些资产收购和管理合同。他成为私人控股公司的创始人、董事长和首席执行官。加入Vanderbilt之前,他负责 Twelfth Evacuation Hospital(越南古芝县)400各床位的培训和管理。他获得Tennessee Technological University的学士学位,医疗管理学院卫生服务证书和California Western University管理学博士学位。
- Ronald Marston,Director since August 2015. Mr. Marston has more than 40 years of experience in international healthcare and is known as an international authority on healthcare systems and trends. In 1973 Mr. Marston joined HCA International now Health Care Corporation of America, a subsidiary of Hospital Corporation of America and was employed there through 1990. In 1980 he was promoted to CEO & Chairman HCA United Kingdom. In 1987 he was promoted to President and CEO of HCA International with responsibility for all development and operations internationally. Under Mr. Marston’s leadership, HCA International grew to include 10 hospitals and seven nursing homes in the United Kingdom; 10 hospitals in Australia; five hospitals and 55 clinics in Central and South America; a management contract for the restructuring of the Singapore General Hospital; a commissioning and management contract for the King Fahad National Guard Hospital in Riyadh, Saudi Arabia; and the longest standing recruitment contract in Saudi Arabia. Hospital Corporation of America sold HCA International in 1989 after the company elected to go private. After the sale, Mr. Marston and his management team acquired certain assets and management contracts and he became the founder, Chairman, and CEO of the resulting privately held company, Health Care Corporation of America, doing business as HCCA International, where he was CEO and President, positions he held until 2010. He sold his interest in HCCA International in 2010 and then started two companies of his own, Southern Manor Living Centers LLC and HCCA Management Company. Mr. Marston was the founder and served as CEO of Southern Manor Living Centers LLC, three assisted living facilities in Tennessee (which he sold in November 2019), and HCCA Management Company, where he is Founder and CEO doing business in the international healthcare industry.Mr. Marston’s previous experience was with Vanderbilt University Medical Center from 1968 to 1973. Prior to joining Vanderbilt, he was responsible for the training and administration of the 400 bed, Twelfth Evacuation Hospital located in Cu Chi, Republic of Vietnam and a graduate of the airborne school in Fort Benning, GA. Mr. Marston holds a B.A. from Tennessee Technological University; a Certificate in Healthcare Administration from the Academy of Health Service; and a Ph.D. in Management from California Western University.
- Henry Cole
-
Henry Cole,2007年以来,他目前担任Global Development International, LLC的总裁,提供医疗和保健计划和产品的公司和不同的项目计划的开发支持、管理和监督,包括 Instant Labs Medical Diagnostics, Inc. (基于分子诊断、医院感染)、 MedPharm, Inc. (全球和发展中国家的医院和诊所的支持)、MPRC Group, LTD(整个中东地区医疗设备、医疗系统规划和支持)和各种其他公司。从1989年到2005年,他曾担任Futures Group International and Futures Group Holdings的总裁和公司官员。在他的领导下,公司的项目扩张到40个国家的办公室。他担任许多组织的董事会职位,包括the Millennium Project(从1996年到2006年)、 the Futures Institute for Sustainable Development(从2001年到2005年)、Foundation Against HIV and AIDS(从2007年到2011年)、Kids Save International(从2006年到2012年)、Triple Win International(从2008年到2013年)和其他。他曾在28个国家任职。深入在埃及、土耳其、加纳、喀麦隆、肯尼亚、苏丹、非洲萨赫勒地区的海地,特立尼达拉岛、巴哈马群岛、菲律宾、印尼和印度体验。他的本科阶段是在Yale University学习。研究生阶段他在 John Hopkins University学习。他学习都是经济学。
Henry Cole,Lead Independent Director, director since August 2015 Chair of the Compensation Committee and member of the Audit Committee. In supporting the Company and its stockholders, Mr. Cole draws on over 40 years of successful executive management and implementation of health and medical programs involving innovations in technology, market development and service delivery. Mr. Cole serves as President of Global Development International, LLC, a position he has held since 2007. In this position he has provided development support, management and oversight for companies and varied program initiatives in medical and healthcare programs and products. This has included Instant Labs Medical Diagnostics, Inc. molecular diagnostics, hospital based infections; MedPharm, Inc. (global and developing country hospital and clinic support); Global MD, Inc. (global physicians network); MPRC Group, LTD, Lebanon and US (medical equipment, medical system planning and support throughout the Middle East); Integrated Health Services LTD, India (health services planning for India); Karishma Health Care LTD, India (hospital medical systems software for India, US, Africa) and various others. Mr. Cole previously served from 2007-2010 as Vice President for Strategy at Camris International, Inc., with focus on technologies and services for infectious disease, for radiation diagnostics, and for pulmonary care. From 1981 to 2005 Mr. Cole served as President and Corporate Officer at Futures Group International and Futures Group Holdings. Under his direction, corporate programs expanded to offices in over 40 countries. At Futures, Mr. Cole oversaw programs that included policy, planning, services and facilities addressing public and private sector infectious disease response in over 35 countries. In addition, he was a founder and served as executive for a subsidiary for national health planning and services (Futures Group UK); for a subsidiary in US rehabilitation services providers (Futures Health Corps); and for a subsidiary in global medical equipment distribution (North Star Health). From 1971-1979 Mr. Cole was Director of Population Programs at the Center for Advanced Studies of General Electric. Earlier he served on the Faculty of Economics, Tulane University (1969 - 1972) and The US President’s Council of Economic Advisors as staff intern (1969 - 1970).Mr. Cole has served on the boards of numerous organizations. Since June 2018 he has been a director of Avant Diagnostics, Inc. (AVDX), a cancer diagnostics company. Mr. Cole’s previous board positions have included: The Millennium Project from 1996 to 2006; the Futures Institute for Sustainable Development from 2001 to 2005; Foundation Against HIV and AIDS from 2007 to 2011; Kids Save International from 2006 to 2012; Triple Win International from 2008 to 2013; and others. He has worked in over 28 countries, with in-depth experience beyond the United States in Egypt, Turkey, Ghana, Cameroon, Kenya, Sudan, Sahelian Africa, Haiti, Trinidad, Bahamas, Philippines, China, Indonesia and India.Mr. Cole holds a B.A. in Economics from Yale University and an MA as well as completed Ph.D. studies (ABD) in Political Economy, with written comprehensive exams and faculty oral exams completed, from The Johns Hopkins University. - Henry Cole,2007年以来,他目前担任Global Development International, LLC的总裁,提供医疗和保健计划和产品的公司和不同的项目计划的开发支持、管理和监督,包括 Instant Labs Medical Diagnostics, Inc. (基于分子诊断、医院感染)、 MedPharm, Inc. (全球和发展中国家的医院和诊所的支持)、MPRC Group, LTD(整个中东地区医疗设备、医疗系统规划和支持)和各种其他公司。从1989年到2005年,他曾担任Futures Group International and Futures Group Holdings的总裁和公司官员。在他的领导下,公司的项目扩张到40个国家的办公室。他担任许多组织的董事会职位,包括the Millennium Project(从1996年到2006年)、 the Futures Institute for Sustainable Development(从2001年到2005年)、Foundation Against HIV and AIDS(从2007年到2011年)、Kids Save International(从2006年到2012年)、Triple Win International(从2008年到2013年)和其他。他曾在28个国家任职。深入在埃及、土耳其、加纳、喀麦隆、肯尼亚、苏丹、非洲萨赫勒地区的海地,特立尼达拉岛、巴哈马群岛、菲律宾、印尼和印度体验。他的本科阶段是在Yale University学习。研究生阶段他在 John Hopkins University学习。他学习都是经济学。
- Henry Cole,Lead Independent Director, director since August 2015 Chair of the Compensation Committee and member of the Audit Committee. In supporting the Company and its stockholders, Mr. Cole draws on over 40 years of successful executive management and implementation of health and medical programs involving innovations in technology, market development and service delivery. Mr. Cole serves as President of Global Development International, LLC, a position he has held since 2007. In this position he has provided development support, management and oversight for companies and varied program initiatives in medical and healthcare programs and products. This has included Instant Labs Medical Diagnostics, Inc. molecular diagnostics, hospital based infections; MedPharm, Inc. (global and developing country hospital and clinic support); Global MD, Inc. (global physicians network); MPRC Group, LTD, Lebanon and US (medical equipment, medical system planning and support throughout the Middle East); Integrated Health Services LTD, India (health services planning for India); Karishma Health Care LTD, India (hospital medical systems software for India, US, Africa) and various others. Mr. Cole previously served from 2007-2010 as Vice President for Strategy at Camris International, Inc., with focus on technologies and services for infectious disease, for radiation diagnostics, and for pulmonary care. From 1981 to 2005 Mr. Cole served as President and Corporate Officer at Futures Group International and Futures Group Holdings. Under his direction, corporate programs expanded to offices in over 40 countries. At Futures, Mr. Cole oversaw programs that included policy, planning, services and facilities addressing public and private sector infectious disease response in over 35 countries. In addition, he was a founder and served as executive for a subsidiary for national health planning and services (Futures Group UK); for a subsidiary in US rehabilitation services providers (Futures Health Corps); and for a subsidiary in global medical equipment distribution (North Star Health). From 1971-1979 Mr. Cole was Director of Population Programs at the Center for Advanced Studies of General Electric. Earlier he served on the Faculty of Economics, Tulane University (1969 - 1972) and The US President’s Council of Economic Advisors as staff intern (1969 - 1970).Mr. Cole has served on the boards of numerous organizations. Since June 2018 he has been a director of Avant Diagnostics, Inc. (AVDX), a cancer diagnostics company. Mr. Cole’s previous board positions have included: The Millennium Project from 1996 to 2006; the Futures Institute for Sustainable Development from 2001 to 2005; Foundation Against HIV and AIDS from 2007 to 2011; Kids Save International from 2006 to 2012; Triple Win International from 2008 to 2013; and others. He has worked in over 28 countries, with in-depth experience beyond the United States in Egypt, Turkey, Ghana, Cameroon, Kenya, Sudan, Sahelian Africa, Haiti, Trinidad, Bahamas, Philippines, China, Indonesia and India.Mr. Cole holds a B.A. in Economics from Yale University and an MA as well as completed Ph.D. studies (ABD) in Political Economy, with written comprehensive exams and faculty oral exams completed, from The Johns Hopkins University.
- Roscoe Moore
-
Roscoe Moore,他担任the United States Department of Health and Human Services “HHS”的职位,负责他职业生涯的最后十二年全球发展的秘书室和HHS支持,专注于非洲大陆和其他欠发达国家。他是一个 the Commissioned Corps of the United States Public Health Service职业军官,进入the U.S. National Institutes of Health并被提拔到HHS的the Immediate Office of the Secretary的美国卫生局局长助理级别。他担任 the U.S. Centers for Disease Control and Prevention (“CDC”)的流行情报部门官员。他担任Center for Veterinary Medicine, U.S. Food and Drug Administration的职位。后来他成为CDC的the National Institute for Occupational Safety and Health的高级流行病学家。他进行了传染病临床研究,医疗器械的安全性和有效性评估,利用医疗器械和辐射的经验和人类健康的影响进行了相关的流行病学研究。从2009年到2013年,他担任NIH的the Fogarty International Center的咨询委员会任职。他担任University of Michigan的公共卫生学院的Alumni Board of Directors职位。他担任Johns Hopkins University的Bloomberg School of Public Health的校长的校友理事会的职位。他担任西雅图the University of Washington的环境卫生附属副教授和南非比勒陀利亚的Medical University of Southern Africa的流行病学副教授。他担任George Washington University的the Africa Center for Health and Human Security的董事会职位。他担任越南University of Hanoi的流行病学副教授。他是 PH RockWood Corporation的创始人兼总裁,从事全球范围内传染性疾病预防、治疗和控制。2009年以来,他担任Biodefense Gamma LLC(从事许多传染性疾病的纯化丙种球蛋白治疗的公司)的董事会职位。2005年以来,他担任the University of Stellenbosch Foundation的信托董事会职位。2004年以来,他担任China Foundation的安全血液的董事会职位。2004年以来,他担任Constituency for Africa的董事会职位并且是其临时主席。他获得Tuskegee Institute的理学学士和兽医博士学位,the University of Michigan的流行病学硕士学位和the Johns Hopkins University的流行病学哲学博士学位。
Roscoe Moore,Director since August 2015. Until his retirement in 2003 Dr. Roscoe M. Moore, Jr. served with the United States Department of Health and Human Services “HHS” and was responsible for the last twelve years of his career for global development support within the Office of the Secretary, HHS, with primary emphasis on Continental Africa and other less-developed countries. Dr. Moore was a career officer within the Commissioned Corps of the United States Public Health Service entering with the U.S. National Institutes of Health and rising to the rank of Assistant United States Surgeon General within the Immediate Office of the Secretary, HHS. Dr. Moore served as an Epidemic Intelligence Service Officer with the U.S. Centers for Disease Control and Prevention (“CDC”). He was with the Center for Veterinary Medicine, U.S. Food and Drug Administration, before becoming Senior Epidemiologist within the National Institute for Occupational Safety and Health, CDC. Dr. Moore has conducted clinical research on infectious diseases, has evaluated the safety and effectiveness of medical devices, and has conducted relevant epidemiological research on the utilization experience and human health effects of medical devices and radiation.Dr. Moore served on the Fogarty International Center Advisory Board of Directors, NIH from 2009 to 2013. He served on the Alumni Board of Directors, School of Public Health, University of Michigan from 1987 to 1993. Dr. Moore served on the Dean’s Alumni Council, Bloomberg School of Public Health, at Johns Hopkins University from 1998 to 2002. He has also served as an Affiliate Associate Professor of Environmental Health for the University of Washington, Seattle from 1994 to 2003 and as an Adjunct Professor of Epidemiology, for the Medical University of Southern Africa, Pretoria, South Africa from 1999 to 2002. He served on the Board of Directors for the Africa Center for Health and Human Security, at George Washington University from 2006 to 2009. Dr. Moore served as an Adjunct Professor of Epidemiology, at University of Hanoi, Vietnam from 1999 to 2002. Dr. Moore is the Founder and President of PH RockWood Corporation, which is focused on the prevention, treatment and control of infectious diseases worldwide. Dr. Moore has served on the Board of Directors for Biodefense Gamma LLC since 2009 a company that specializes in purified gamma globulin therapy for a number of infectious diseases. Dr. Moore serves on the Board of Trustees for Friends of the University of Stellenbosch Foundation, a position he has held since 2005 the Board of Directors for the Safe Blood for China Foundation, a position he has held since 2004 and the Board of Directors for Constituency for Africa since 2004 and served as its Interim Chairman. Dr. Moore currently serves on the Board of Directors of Immune Therapeutics (OTC: IMUN), a position he has held since 2018. Dr. Moore currently serves on the Board of Advisors for the Institute of Human Virology, School of Medicine, University of Maryland, and the Board of Directors for the Global Virus Network since September 2019.Dr. Moore served as Chairperson for the Washington Suburban Sanitation Commission (2011-2012) which has an annual budget of $1.7 billion. Dr. Moore served as Commissioner for the Maryland Health Care Commission, appointed by the Governor of Maryland in 2008. Dr. Moore received his B.S. and Doctor of Veterinary Medicine degrees from Tuskegee Institute; his Masters of Public Health degree in Epidemiology from the University of Michigan; and his Ph.D. in Epidemiology from the Johns Hopkins University. - Roscoe Moore,他担任the United States Department of Health and Human Services “HHS”的职位,负责他职业生涯的最后十二年全球发展的秘书室和HHS支持,专注于非洲大陆和其他欠发达国家。他是一个 the Commissioned Corps of the United States Public Health Service职业军官,进入the U.S. National Institutes of Health并被提拔到HHS的the Immediate Office of the Secretary的美国卫生局局长助理级别。他担任 the U.S. Centers for Disease Control and Prevention (“CDC”)的流行情报部门官员。他担任Center for Veterinary Medicine, U.S. Food and Drug Administration的职位。后来他成为CDC的the National Institute for Occupational Safety and Health的高级流行病学家。他进行了传染病临床研究,医疗器械的安全性和有效性评估,利用医疗器械和辐射的经验和人类健康的影响进行了相关的流行病学研究。从2009年到2013年,他担任NIH的the Fogarty International Center的咨询委员会任职。他担任University of Michigan的公共卫生学院的Alumni Board of Directors职位。他担任Johns Hopkins University的Bloomberg School of Public Health的校长的校友理事会的职位。他担任西雅图the University of Washington的环境卫生附属副教授和南非比勒陀利亚的Medical University of Southern Africa的流行病学副教授。他担任George Washington University的the Africa Center for Health and Human Security的董事会职位。他担任越南University of Hanoi的流行病学副教授。他是 PH RockWood Corporation的创始人兼总裁,从事全球范围内传染性疾病预防、治疗和控制。2009年以来,他担任Biodefense Gamma LLC(从事许多传染性疾病的纯化丙种球蛋白治疗的公司)的董事会职位。2005年以来,他担任the University of Stellenbosch Foundation的信托董事会职位。2004年以来,他担任China Foundation的安全血液的董事会职位。2004年以来,他担任Constituency for Africa的董事会职位并且是其临时主席。他获得Tuskegee Institute的理学学士和兽医博士学位,the University of Michigan的流行病学硕士学位和the Johns Hopkins University的流行病学哲学博士学位。
- Roscoe Moore,Director since August 2015. Until his retirement in 2003 Dr. Roscoe M. Moore, Jr. served with the United States Department of Health and Human Services “HHS” and was responsible for the last twelve years of his career for global development support within the Office of the Secretary, HHS, with primary emphasis on Continental Africa and other less-developed countries. Dr. Moore was a career officer within the Commissioned Corps of the United States Public Health Service entering with the U.S. National Institutes of Health and rising to the rank of Assistant United States Surgeon General within the Immediate Office of the Secretary, HHS. Dr. Moore served as an Epidemic Intelligence Service Officer with the U.S. Centers for Disease Control and Prevention (“CDC”). He was with the Center for Veterinary Medicine, U.S. Food and Drug Administration, before becoming Senior Epidemiologist within the National Institute for Occupational Safety and Health, CDC. Dr. Moore has conducted clinical research on infectious diseases, has evaluated the safety and effectiveness of medical devices, and has conducted relevant epidemiological research on the utilization experience and human health effects of medical devices and radiation.Dr. Moore served on the Fogarty International Center Advisory Board of Directors, NIH from 2009 to 2013. He served on the Alumni Board of Directors, School of Public Health, University of Michigan from 1987 to 1993. Dr. Moore served on the Dean’s Alumni Council, Bloomberg School of Public Health, at Johns Hopkins University from 1998 to 2002. He has also served as an Affiliate Associate Professor of Environmental Health for the University of Washington, Seattle from 1994 to 2003 and as an Adjunct Professor of Epidemiology, for the Medical University of Southern Africa, Pretoria, South Africa from 1999 to 2002. He served on the Board of Directors for the Africa Center for Health and Human Security, at George Washington University from 2006 to 2009. Dr. Moore served as an Adjunct Professor of Epidemiology, at University of Hanoi, Vietnam from 1999 to 2002. Dr. Moore is the Founder and President of PH RockWood Corporation, which is focused on the prevention, treatment and control of infectious diseases worldwide. Dr. Moore has served on the Board of Directors for Biodefense Gamma LLC since 2009 a company that specializes in purified gamma globulin therapy for a number of infectious diseases. Dr. Moore serves on the Board of Trustees for Friends of the University of Stellenbosch Foundation, a position he has held since 2005 the Board of Directors for the Safe Blood for China Foundation, a position he has held since 2004 and the Board of Directors for Constituency for Africa since 2004 and served as its Interim Chairman. Dr. Moore currently serves on the Board of Directors of Immune Therapeutics (OTC: IMUN), a position he has held since 2018. Dr. Moore currently serves on the Board of Advisors for the Institute of Human Virology, School of Medicine, University of Maryland, and the Board of Directors for the Global Virus Network since September 2019.Dr. Moore served as Chairperson for the Washington Suburban Sanitation Commission (2011-2012) which has an annual budget of $1.7 billion. Dr. Moore served as Commissioner for the Maryland Health Care Commission, appointed by the Governor of Maryland in 2008. Dr. Moore received his B.S. and Doctor of Veterinary Medicine degrees from Tuskegee Institute; his Masters of Public Health degree in Epidemiology from the University of Michigan; and his Ph.D. in Epidemiology from the Johns Hopkins University.
- Matthew L. Cypher
-
Matthew L. Cypher,2015年4月以来,他加入Georgetown University的McDonough School of Business并担任房地产融资计划董事(the Steers Center for Global Real Estate)。他担任研究生和本科生的水平的房地产教授和特制产品课程来教授房地产资本市场的四个象限——公共、私人债务和股本。从2005年到2012年,他担任Invesco Real Estate的董事,负责承销部门的监管。在他领导期间,公司收购了价值102亿美元的机构房地产。2011年6月他本人同意支付15亿美元收购最终购买纽约230 Park Avenue(Invesco代表其顾客资本收购)。他负责集团估值,营销Invesco130亿美元的北美投资组合。他担任公司的投资委员会和投资策略部门成员。他担任Southern Methodist University的兼职教授以及阿林顿的University of Texas的客座教授。他获得Penn State University的学士学位和Texas A&M University的硕士和博士学位。
Matthew L. Cypher,Director since March 2016. In July 2012 Dr. Cypher joined the faculty at Georgetown University’s McDonough School of Business as the director of the Real Estate Finance Initiative since April 2015 the Steers Center for Global Real Estate. He serves as an Atara Kaufman Professor of Real Estate at both the graduate and undergraduate levels and tailors coursework to teach the Four Quadrants of the real estate capital markets - public, private, debt and equity. From 2005 to 2012 he served as a director at Invesco Real Estate where he was responsible for oversight of the underwriting group, which acquired $10.2 billion worth of institutional real estate during his leadership tenure. Dr. Cypher personally underwrote $1.5 billion of acquisitions culminating with the purchase of 230 Park Avenue in New York, which Invesco acquired on behalf of its client capital in June 2011. He also oversaw the valuations group, which marked to market Invesco’s more than $13 billion North American portfolio, and served as a member of the firm’s investment committee and investment strategy group. He has held positions as an Adjunct Professor at Southern Methodist University and a Visiting Professor at University of Texas at Arlington.Dr. Cypher holds a B.A. from Penn State University and a Masters and a Ph.D. from Texas A&M University. - Matthew L. Cypher,2015年4月以来,他加入Georgetown University的McDonough School of Business并担任房地产融资计划董事(the Steers Center for Global Real Estate)。他担任研究生和本科生的水平的房地产教授和特制产品课程来教授房地产资本市场的四个象限——公共、私人债务和股本。从2005年到2012年,他担任Invesco Real Estate的董事,负责承销部门的监管。在他领导期间,公司收购了价值102亿美元的机构房地产。2011年6月他本人同意支付15亿美元收购最终购买纽约230 Park Avenue(Invesco代表其顾客资本收购)。他负责集团估值,营销Invesco130亿美元的北美投资组合。他担任公司的投资委员会和投资策略部门成员。他担任Southern Methodist University的兼职教授以及阿林顿的University of Texas的客座教授。他获得Penn State University的学士学位和Texas A&M University的硕士和博士学位。
- Matthew L. Cypher,Director since March 2016. In July 2012 Dr. Cypher joined the faculty at Georgetown University’s McDonough School of Business as the director of the Real Estate Finance Initiative since April 2015 the Steers Center for Global Real Estate. He serves as an Atara Kaufman Professor of Real Estate at both the graduate and undergraduate levels and tailors coursework to teach the Four Quadrants of the real estate capital markets - public, private, debt and equity. From 2005 to 2012 he served as a director at Invesco Real Estate where he was responsible for oversight of the underwriting group, which acquired $10.2 billion worth of institutional real estate during his leadership tenure. Dr. Cypher personally underwrote $1.5 billion of acquisitions culminating with the purchase of 230 Park Avenue in New York, which Invesco acquired on behalf of its client capital in June 2011. He also oversaw the valuations group, which marked to market Invesco’s more than $13 billion North American portfolio, and served as a member of the firm’s investment committee and investment strategy group. He has held positions as an Adjunct Professor at Southern Methodist University and a Visiting Professor at University of Texas at Arlington.Dr. Cypher holds a B.A. from Penn State University and a Masters and a Ph.D. from Texas A&M University.
- Zhang Huiqi
-
Zhang Huiqi,她于2016年3月30日被任命为董事。她目前是Henan Hongguang Real Estate Limited(公司主要从事中国房地产开发)、Henan Zensun Corporate Development Company Limited(公司主要从事房地产建设和管理)的监事。她曾担任Henan Hongguang Real Estate Limited公司(2013年1月以来)、Henan Zensun Corporate Development Company Limited(2013年9月以来)的监事职务。这些公司由张敬国先生控制。她是张敬国先生的女儿。任职Heng Hongguang Real Estate Limited 、Henan Zensun Corporate Development Company Limited之前,她曾是全职学生。她毕业于the University College London,并于2015年获得科学项目和企业管理硕士学位。她持有the University of Leicester的管理硕士学位(2013年),以及Beijing Forestry University的工程管理学士学位(信息管理与信息系统)(2011年)。
Zhang Huiqi,Director since March 2016. Ms. Zhang is currently a Non-Executive Director of Xingye Wulian Service Group Co. Ltd., whose shares are listed on the Main Board of The Stock Exchange of Hong Kong Limited Stock Code:9916 and the supervisor for Henan Hongguang Real Estate Limited, a company primarily engaged in property development in China, and Henan Zensun Corporate Development Group Company Limited, a company mainly engaged in investment of city infrastructure and related public facilities, finance, commerce, tourism, culture, hotel and agriculture, as well as providing consulting services in investment management, asset management and business administration. She has held such supervisory position since January 2013 for Henan Hongguang Real Estate Limited and September 2013 for Henan Zensun Corporate Development Company Limited. These companies are controlled by Mr. Zhang Jingguo. Ms. Zhang is the daughter of Mr. Zhang Jingguo.Prior to Heng Hongguang Real Estate Limited and Henan Zensun Corporate Development Company Limited, Ms. Zhang was a full-time student. Ms. Zhang graduated from the University College London and obtained a Master of Science in Project and Enterprise Management in 2015. She holds a Master of Science in Management from the University of Leicester -2013 and a Bachelor of Management in Business Administration (Information Management and Information Systems) from Beijing Forestry University 2011. - Zhang Huiqi,她于2016年3月30日被任命为董事。她目前是Henan Hongguang Real Estate Limited(公司主要从事中国房地产开发)、Henan Zensun Corporate Development Company Limited(公司主要从事房地产建设和管理)的监事。她曾担任Henan Hongguang Real Estate Limited公司(2013年1月以来)、Henan Zensun Corporate Development Company Limited(2013年9月以来)的监事职务。这些公司由张敬国先生控制。她是张敬国先生的女儿。任职Heng Hongguang Real Estate Limited 、Henan Zensun Corporate Development Company Limited之前,她曾是全职学生。她毕业于the University College London,并于2015年获得科学项目和企业管理硕士学位。她持有the University of Leicester的管理硕士学位(2013年),以及Beijing Forestry University的工程管理学士学位(信息管理与信息系统)(2011年)。
- Zhang Huiqi,Director since March 2016. Ms. Zhang is currently a Non-Executive Director of Xingye Wulian Service Group Co. Ltd., whose shares are listed on the Main Board of The Stock Exchange of Hong Kong Limited Stock Code:9916 and the supervisor for Henan Hongguang Real Estate Limited, a company primarily engaged in property development in China, and Henan Zensun Corporate Development Group Company Limited, a company mainly engaged in investment of city infrastructure and related public facilities, finance, commerce, tourism, culture, hotel and agriculture, as well as providing consulting services in investment management, asset management and business administration. She has held such supervisory position since January 2013 for Henan Hongguang Real Estate Limited and September 2013 for Henan Zensun Corporate Development Company Limited. These companies are controlled by Mr. Zhang Jingguo. Ms. Zhang is the daughter of Mr. Zhang Jingguo.Prior to Heng Hongguang Real Estate Limited and Henan Zensun Corporate Development Company Limited, Ms. Zhang was a full-time student. Ms. Zhang graduated from the University College London and obtained a Master of Science in Project and Enterprise Management in 2015. She holds a Master of Science in Management from the University of Leicester -2013 and a Bachelor of Management in Business Administration (Information Management and Information Systems) from Beijing Forestry University 2011.
- Paula Crowley
-
Paula Crowley,自2018年6月起担任董事。Crowley女士拥有超过40年的房地产经验,曾在Anchor Health Properties“;Anchor”;工作,该公司由她于1987年共同创立,并担任首席执行官,直到2015年10月Anchor被出售给Brinkman管理和开发。自2015年10月起,Crowley女士继续参与Anchor,从2015年10月至2017年11月担任其主席,并自2017年11月起担任名誉主席。Anchor是一家专注于梦百合物业的全国性全方位房地产开发、管理和投资公司。任职Anchor公司之前,她曾担任the Rouse Company of Columbia(位于马里兰州)的开发董事8年,在那里她曾负责城市零售项目的开发。克劳利曾担任宾夕法尼亚州兰开斯特市高级公司的董事会主席至2019年10月,以及位于宾夕法尼亚州费城的非营利组织Women’;s Way的董事会主席。截至2020年2月,克劳利女士被任命为费城Kaiserman公司的董事会主席。Crowley女士是维拉诺瓦大学(Villanova University)金融系MBA项目的兼职教授。Crowley获得Middlebury College文学学士学位、University of Pennsylvania城市规划硕士学位和University of Pennsylvania Wharton School工商管理硕士学位。
Paula Crowley,Director since June 2018. Ms. Crowley has over 40 years of real estate experience and has worked with Anchor Health Properties “Anchor”, which she co-founded in 1987 and served as Chief Executive Officer until October 2015 when Anchor was sold to Brinkman Management and Development. Since October 2015 Ms. Crowley has continued to be involved with Anchor, serving as its Chairman from October 2015 through November 2017 and as its Chair Emeritus since November 2017. Anchor is a national full-service real estate development, management and investment company that focuses on healthcare properties. Prior to Anchor, Ms. Crowley spent eight years as Development Director with The Rouse Company of Columbia, Maryland, where she was responsible for the development of urban retail projects.Ms. Crowley served as Chair of the Board of the High Companies in Lancaster, Pennsylvania through October 2019 as well as Chair of the Board of Women’s Way, a not-for-profit organization based in Philadelphia, Pennsylvania. As of February 2020 Ms. Crowley was appointed Chair of the Board of the Kaiserman Company in Philadelphia. Ms. Crowley is an adjunct professor at the MBA program at Villanova University in the Finance Department.Ms. Crowley received a BA from Middlebury College, a Masters in City Planning from the University of Pennsylvania and an MBA from the University of Pennsylvania Wharton School. - Paula Crowley,自2018年6月起担任董事。Crowley女士拥有超过40年的房地产经验,曾在Anchor Health Properties“;Anchor”;工作,该公司由她于1987年共同创立,并担任首席执行官,直到2015年10月Anchor被出售给Brinkman管理和开发。自2015年10月起,Crowley女士继续参与Anchor,从2015年10月至2017年11月担任其主席,并自2017年11月起担任名誉主席。Anchor是一家专注于梦百合物业的全国性全方位房地产开发、管理和投资公司。任职Anchor公司之前,她曾担任the Rouse Company of Columbia(位于马里兰州)的开发董事8年,在那里她曾负责城市零售项目的开发。克劳利曾担任宾夕法尼亚州兰开斯特市高级公司的董事会主席至2019年10月,以及位于宾夕法尼亚州费城的非营利组织Women’;s Way的董事会主席。截至2020年2月,克劳利女士被任命为费城Kaiserman公司的董事会主席。Crowley女士是维拉诺瓦大学(Villanova University)金融系MBA项目的兼职教授。Crowley获得Middlebury College文学学士学位、University of Pennsylvania城市规划硕士学位和University of Pennsylvania Wharton School工商管理硕士学位。
- Paula Crowley,Director since June 2018. Ms. Crowley has over 40 years of real estate experience and has worked with Anchor Health Properties “Anchor”, which she co-founded in 1987 and served as Chief Executive Officer until October 2015 when Anchor was sold to Brinkman Management and Development. Since October 2015 Ms. Crowley has continued to be involved with Anchor, serving as its Chairman from October 2015 through November 2017 and as its Chair Emeritus since November 2017. Anchor is a national full-service real estate development, management and investment company that focuses on healthcare properties. Prior to Anchor, Ms. Crowley spent eight years as Development Director with The Rouse Company of Columbia, Maryland, where she was responsible for the development of urban retail projects.Ms. Crowley served as Chair of the Board of the High Companies in Lancaster, Pennsylvania through October 2019 as well as Chair of the Board of Women’s Way, a not-for-profit organization based in Philadelphia, Pennsylvania. As of February 2020 Ms. Crowley was appointed Chair of the Board of the Kaiserman Company in Philadelphia. Ms. Crowley is an adjunct professor at the MBA program at Villanova University in the Finance Department.Ms. Crowley received a BA from Middlebury College, a Masters in City Planning from the University of Pennsylvania and an MBA from the University of Pennsylvania Wharton School.
- Lori Wittman
-
Lori Wittman, 首席财务官和风险官。她也是公司附属子公司BRP管理有限公司的首席财务官和管理负责人,她自2006年开始担任该职位。她也是公司附属子公司ALDA资本有限公司首席财务官、首席合规官和风险官。从2000年到2006年她担任通用资产成长有限公司(在纽约证券交易所上市交易的公共房地产投资信托基金)高级副总裁和风险官。她还负责劳斯公司120亿美元的收购融资工作。
Lori Wittman has served as an advisor to Big Rock Partners Acquisition Corp. "Big Rock", a blank check company, since February 2020. From September 2017 to February 2020 Ms. Wittman served as Chief Financial Officer and a member of the Board of Directors of Big Rock. From August 2015 to August 2017 Ms. Wittman was the Chief Financial Officer of Care Capital Properties, Inc. (NYSE: CCP), a public healthcare REIT with a diversified portfolio of triple-net leased properties, which merged with Sabra Healthcare REIT, Inc. in 2017. Previously, Ms. Wittman was Senior Vice President of Capital Markets and Investor Relations at Ventas, Inc., a REIT focused on the healthcare sector from 2011 to August 2015. Prior to her time at Ventas, Ms. Wittman served in a number of finance, accounting and capital markets-related roles at various companies, including General Growth Properties, Big Rock Partners, LLC and Heitman Financial. Ms. Wittman has been a director of IMH Financial Corporation ("IMH"), a real estate investment and finance company, since July 2014 and currently serves as Chairperson of the Compensation Committee and as a member of the Audit Committee of IMH. Ms. Wittman has also served as a director of Global Medical REIT Inc. (NYSE: GMRE), a REIT engaged primarily in the acquisition of healthcare facilities, since May 2018 and currently serves as Chairperson of the Audit Committee and a member of the Compensation Committee of GMRE. Ms. Wittman also serves as a director of Freehold Properties, a real estate investment company, and currently serves as the Chair of the Audit Committee. Ms. Wittman received an M.B.A., Finance and Accounting from the University of Chicago, an M.C.P., Housing and Real Estate Finance from the University of Pennsylvania and a B.A. from Clark University. - Lori Wittman, 首席财务官和风险官。她也是公司附属子公司BRP管理有限公司的首席财务官和管理负责人,她自2006年开始担任该职位。她也是公司附属子公司ALDA资本有限公司首席财务官、首席合规官和风险官。从2000年到2006年她担任通用资产成长有限公司(在纽约证券交易所上市交易的公共房地产投资信托基金)高级副总裁和风险官。她还负责劳斯公司120亿美元的收购融资工作。
- Lori Wittman has served as an advisor to Big Rock Partners Acquisition Corp. "Big Rock", a blank check company, since February 2020. From September 2017 to February 2020 Ms. Wittman served as Chief Financial Officer and a member of the Board of Directors of Big Rock. From August 2015 to August 2017 Ms. Wittman was the Chief Financial Officer of Care Capital Properties, Inc. (NYSE: CCP), a public healthcare REIT with a diversified portfolio of triple-net leased properties, which merged with Sabra Healthcare REIT, Inc. in 2017. Previously, Ms. Wittman was Senior Vice President of Capital Markets and Investor Relations at Ventas, Inc., a REIT focused on the healthcare sector from 2011 to August 2015. Prior to her time at Ventas, Ms. Wittman served in a number of finance, accounting and capital markets-related roles at various companies, including General Growth Properties, Big Rock Partners, LLC and Heitman Financial. Ms. Wittman has been a director of IMH Financial Corporation ("IMH"), a real estate investment and finance company, since July 2014 and currently serves as Chairperson of the Compensation Committee and as a member of the Audit Committee of IMH. Ms. Wittman has also served as a director of Global Medical REIT Inc. (NYSE: GMRE), a REIT engaged primarily in the acquisition of healthcare facilities, since May 2018 and currently serves as Chairperson of the Audit Committee and a member of the Compensation Committee of GMRE. Ms. Wittman also serves as a director of Freehold Properties, a real estate investment company, and currently serves as the Chair of the Audit Committee. Ms. Wittman received an M.B.A., Finance and Accounting from the University of Chicago, an M.C.P., Housing and Real Estate Finance from the University of Pennsylvania and a B.A. from Clark University.
高管简历
中英对照 |  中文 |  英文- Jeffrey Busch
Jeffrey Busch, 2014年9月起担任董事。Busch先生自1985年以来一直是房地产行业的积极投资者。Busch先生自2015年8月起担任公司董事长兼总裁,自2017年8月起担任公司首席执行官。他的经验包括开发各种资产类别的众多物业,拥有和管理几个州的房地产,包括租赁住房和各种各样的商业房地产。2001年以来,他还担任Safe Blood International Foundation的总裁,在那里他监督35个发展中国家的医疗设施的建立,由CDC和USAID、埃克森美孚和盖茨基金会资助。布什曾在两届总统政府中被任命为总统,一次是在住房和城市事务部(Department of Housing and Urban Affairs),另一次是在日内瓦的联合国(United Nations)担任美国代表。在本代理声明的“薪酬、讨论和分析”部分讨论我们的内部化之前,Busch先生担任Inter-American Management LLC的总裁,我们的前外部顾问(“IAM”)或我们的“前顾问”,以及自2013年以来的董事,并且是IAM的母公司Inter-American Group Holdings Inc.(“IAGH”)的15股已发行普通股的所有者。自2014年10月以来,Busch先生一直担任American Housing REIT Inc.(以前由IAM管理)的董事会主席。Busch先生曾担任American Pacific Bankcorp, Inc. (APB)的董事至2020年2月。Busch先生还担任癌症诊断公司Avant Diagnostics, Inc. (AVDX)的董事会主席,以及OncBioMune Pharmaceuticals, Inc.(专门从事创新癌症治疗疗法的生物技术公司)的董事会主席。他持有纽约大学斯特恩商学院的学士学位、纽约大学公共管理硕士学位和埃默里大学的法学博士学位。
Jeffrey Busch,Director since September 2014. Mr. Busch has been an active investor in the real estate industry since 1985. Mr. Busch also has served as Chairman and President of Company from August 2015 to present and has served as Chief Executive Officer of Company since August 2017. His experience includes developing numerous properties in various asset classes, owning and managing real estate in several states, including rental housing, and a wide variety of commercial real estate. Since 2001 Mr. Busch has also served as President of Safe Blood International Foundation, where he oversees the establishment of medical facilities in 35 developing nations, funded by the CDC and USAID, Exxon Mobil,and the Gates Foundation. Mr. Busch has had presidential appointments in two presidential administrations, one in the Department of Housing and Urban Affairs and the other at the United Nations in Geneva, where he served as a United States delegate. Prior to Internalization which is discussed in the "Compensation, Discussion and Analysis" section of this Proxy Statement, Mr. Busch served as President of Inter-American Management LLC, former external advisor ("IAM") or "Former Advisor", as well as a Director since 2013 and was an owner of 15 of the outstanding common stock of Inter-American Group Holdings Inc. ("IAGH"), the parent company of IAM. Since October 2014 Mr. Busch has served as Chairman of the Board of American Housing REIT Inc., which was formerly managed by IAM. Mr. Busch served as a director of American Pacific Bankcorp, Inc. (APB) through February 2020. Mr. Busch also serves as the Chairman of the Board of Directors of Avant Diagnostics, Inc. (AVDX), a cancer diagnostics company, and the Chairman of the Board of Directors of OncBioMune Pharmaceuticals, Inc., a biotechnology company specializing in innovative cancer treatment therapies. Mr. Busch holds a B.A. from New York University in the Stern School of Business, a Masters of Public Administration from New York University, and a J.D. from Emory University.- Jeffrey Busch, 2014年9月起担任董事。Busch先生自1985年以来一直是房地产行业的积极投资者。Busch先生自2015年8月起担任公司董事长兼总裁,自2017年8月起担任公司首席执行官。他的经验包括开发各种资产类别的众多物业,拥有和管理几个州的房地产,包括租赁住房和各种各样的商业房地产。2001年以来,他还担任Safe Blood International Foundation的总裁,在那里他监督35个发展中国家的医疗设施的建立,由CDC和USAID、埃克森美孚和盖茨基金会资助。布什曾在两届总统政府中被任命为总统,一次是在住房和城市事务部(Department of Housing and Urban Affairs),另一次是在日内瓦的联合国(United Nations)担任美国代表。在本代理声明的“薪酬、讨论和分析”部分讨论我们的内部化之前,Busch先生担任Inter-American Management LLC的总裁,我们的前外部顾问(“IAM”)或我们的“前顾问”,以及自2013年以来的董事,并且是IAM的母公司Inter-American Group Holdings Inc.(“IAGH”)的15股已发行普通股的所有者。自2014年10月以来,Busch先生一直担任American Housing REIT Inc.(以前由IAM管理)的董事会主席。Busch先生曾担任American Pacific Bankcorp, Inc. (APB)的董事至2020年2月。Busch先生还担任癌症诊断公司Avant Diagnostics, Inc. (AVDX)的董事会主席,以及OncBioMune Pharmaceuticals, Inc.(专门从事创新癌症治疗疗法的生物技术公司)的董事会主席。他持有纽约大学斯特恩商学院的学士学位、纽约大学公共管理硕士学位和埃默里大学的法学博士学位。
- Jeffrey Busch,Director since September 2014. Mr. Busch has been an active investor in the real estate industry since 1985. Mr. Busch also has served as Chairman and President of Company from August 2015 to present and has served as Chief Executive Officer of Company since August 2017. His experience includes developing numerous properties in various asset classes, owning and managing real estate in several states, including rental housing, and a wide variety of commercial real estate. Since 2001 Mr. Busch has also served as President of Safe Blood International Foundation, where he oversees the establishment of medical facilities in 35 developing nations, funded by the CDC and USAID, Exxon Mobil,and the Gates Foundation. Mr. Busch has had presidential appointments in two presidential administrations, one in the Department of Housing and Urban Affairs and the other at the United Nations in Geneva, where he served as a United States delegate. Prior to Internalization which is discussed in the "Compensation, Discussion and Analysis" section of this Proxy Statement, Mr. Busch served as President of Inter-American Management LLC, former external advisor ("IAM") or "Former Advisor", as well as a Director since 2013 and was an owner of 15 of the outstanding common stock of Inter-American Group Holdings Inc. ("IAGH"), the parent company of IAM. Since October 2014 Mr. Busch has served as Chairman of the Board of American Housing REIT Inc., which was formerly managed by IAM. Mr. Busch served as a director of American Pacific Bankcorp, Inc. (APB) through February 2020. Mr. Busch also serves as the Chairman of the Board of Directors of Avant Diagnostics, Inc. (AVDX), a cancer diagnostics company, and the Chairman of the Board of Directors of OncBioMune Pharmaceuticals, Inc., a biotechnology company specializing in innovative cancer treatment therapies. Mr. Busch holds a B.A. from New York University in the Stern School of Business, a Masters of Public Administration from New York University, and a J.D. from Emory University.
- Alfonzo Leon
Alfonzo Leon,他于2014年8月加入公司,并担任首席投资官(2015年7月1日以来)。他是拥有15年收购和资本市场经验的房地产财务主管,代表机构投资者约100项完成的价值30亿美元的交易。加入我们公司之前,他担任Cain Brothers & Company(位于纽约和旧金山外,卫生保健的专业投资银行公司)的房地产并购和资本市场集团的高级副总裁。他于2005年加入Cain Brothers,并与医保范围的主要客户合作,包括一些卫生系统、多专业医师团体、高级住房运营商、非贸易和在纽约证交所(NYSE)上市的房地产投资信托基金、医疗保健开发人员和私人股本基金。任职Cain Brothers之前,他曾是LaSalle Investment Management(国际投资顾问公司)的国际投资顾问部门员工。他于2000年加入LaSalle,并代表机构投资者收购8亿美元的多户型、办公、医疗办公室以及工业产权,包括全国最大的养老基金、大学捐赠基金和主权财富基金。LaSalle Investment Management是全球顾问公司Jones Lang LaSalle(NYSE:JLL)的子公司。
Alfonzo Leon joined the Company in August 2014 and has served as Chief Investment Officer since July 1 2015. Mr. Leon is a real estate finance executive with 19 years of acquisition and capital markets experience working on behalf of institutional investors, real estate developers, and healthcare operators. Prior to joining our Company, Mr. Leon was a Senior Vice President with Cain Brothers & Company, a boutique healthcare investment banking firm based out of New York and San Francisco, in their real estate M&A and capital markets group. Mr. Leon joined Cain Brothers in 2005 and completed $2 billion in real estate transactions with leading clients across the healthcare spectrum including health systems, multi-specialty physician groups, senior housing operators, non-traded and NYSE-listed REITs, healthcare developers, and private equity funds. Prior to Cain Brothers, Mr. Leon was an associate with LaSalle Investment Management, an international investment advisor firm, in their North American acquisition group. Mr. Leon joined LaSalle in 2000 and acquired $800 million in multi-family, office, medical office, and industrial property on behalf of institutional investors that include the nation’s largest pension funds and college endowments and a number of sovereign wealth funds. LaSalle Investment Management is a subsidiary of global consultancy firm Jones Lang LaSalle NYSE: JLL.Mr. Leon’s experience includes managing commercial real estate transactions ranging from $5 million to $500 million, raising capital for real estate developers, structuring joint ventures between developers and investors, completing portfolio investment sales to healthcare REITs, structuring sale-leasebacks for physician groups, acquisitions and dispositions for separate and commingled funds, corporate real estate M&A, structuring credit tenant lease financing for investment grade health systems, and strategic real estate advisory for health systems. Mr. Leon’s property type expertise within the healthcare sector includes medical office, outpatient facilities, surgical facilities, post-acute facilities, senior housing, and hospitals. Mr. Leon received his Master’s degree in real estate finance from the Massachusetts Institutes of Technology and his B.S. in Architecture from the University of Virginia.- Alfonzo Leon,他于2014年8月加入公司,并担任首席投资官(2015年7月1日以来)。他是拥有15年收购和资本市场经验的房地产财务主管,代表机构投资者约100项完成的价值30亿美元的交易。加入我们公司之前,他担任Cain Brothers & Company(位于纽约和旧金山外,卫生保健的专业投资银行公司)的房地产并购和资本市场集团的高级副总裁。他于2005年加入Cain Brothers,并与医保范围的主要客户合作,包括一些卫生系统、多专业医师团体、高级住房运营商、非贸易和在纽约证交所(NYSE)上市的房地产投资信托基金、医疗保健开发人员和私人股本基金。任职Cain Brothers之前,他曾是LaSalle Investment Management(国际投资顾问公司)的国际投资顾问部门员工。他于2000年加入LaSalle,并代表机构投资者收购8亿美元的多户型、办公、医疗办公室以及工业产权,包括全国最大的养老基金、大学捐赠基金和主权财富基金。LaSalle Investment Management是全球顾问公司Jones Lang LaSalle(NYSE:JLL)的子公司。
- Alfonzo Leon joined the Company in August 2014 and has served as Chief Investment Officer since July 1 2015. Mr. Leon is a real estate finance executive with 19 years of acquisition and capital markets experience working on behalf of institutional investors, real estate developers, and healthcare operators. Prior to joining our Company, Mr. Leon was a Senior Vice President with Cain Brothers & Company, a boutique healthcare investment banking firm based out of New York and San Francisco, in their real estate M&A and capital markets group. Mr. Leon joined Cain Brothers in 2005 and completed $2 billion in real estate transactions with leading clients across the healthcare spectrum including health systems, multi-specialty physician groups, senior housing operators, non-traded and NYSE-listed REITs, healthcare developers, and private equity funds. Prior to Cain Brothers, Mr. Leon was an associate with LaSalle Investment Management, an international investment advisor firm, in their North American acquisition group. Mr. Leon joined LaSalle in 2000 and acquired $800 million in multi-family, office, medical office, and industrial property on behalf of institutional investors that include the nation’s largest pension funds and college endowments and a number of sovereign wealth funds. LaSalle Investment Management is a subsidiary of global consultancy firm Jones Lang LaSalle NYSE: JLL.Mr. Leon’s experience includes managing commercial real estate transactions ranging from $5 million to $500 million, raising capital for real estate developers, structuring joint ventures between developers and investors, completing portfolio investment sales to healthcare REITs, structuring sale-leasebacks for physician groups, acquisitions and dispositions for separate and commingled funds, corporate real estate M&A, structuring credit tenant lease financing for investment grade health systems, and strategic real estate advisory for health systems. Mr. Leon’s property type expertise within the healthcare sector includes medical office, outpatient facilities, surgical facilities, post-acute facilities, senior housing, and hospitals. Mr. Leon received his Master’s degree in real estate finance from the Massachusetts Institutes of Technology and his B.S. in Architecture from the University of Virginia.
- Danica Holley
Danica Holley,2016年3月30日以来,她一直担任首席运营官。她的业务开发和管理经验包括在国际环境任职超过18年。她在国际项目管理、政府采购和全球业务交付和初创企业中有丰富经验。从2008年4月15日到现在,她担任Safe Blood International Foundation的执行董事,负责监督在非洲和亚洲的国家卫生计划,包括Ebola反应项目。她担任许多管理职务,包括 WorldSpace, Inc.的战略和公司业务发展董事(从1997年到2000年)、ISI Professional Services的企业和业务营销董事(从2000年到2001年)、Tanzus Development的行政董事(从1996年到1997年)和SK&I Architectural Design Group, LLC的董事(从2003年到2007年)。她拥有10年的跨学科管理复杂的服务交付跨国团队的经验。她持有美国Georgetown大学Edmund Walsh School of Foreign Service的国际法律、政治和组织外交服务学士学位,以及非洲研究证书,并精通阿拉伯语(1994年5月)。她在School for International Training(佛蒙特州伯瑞特波罗和摩洛哥拉巴特)学习国际组织(1993年1月到6月)。她是ICF认证行政领导教练,也是Georgetown大学的Graduate Leadership Coaching Program的校友(2010年9月)。
Danica Holley has served as a member of the Board since August 2021. Ms. Holley has served as the chief operating officer of Global Medical REIT Inc. since March 2016. Ms. Holley's business development and management experience spans more than 18 years with an emphasis on working in an international environment. She has extensive experience in international program management, government procurement, and global business rollouts and start-ups. As executive director for Safe Blood International Foundation since April 2008 she oversaw national health initiatives in Africa and Asia, including an Ebola response project. Ms. Holley has held management positions as director of strategy, corporate business development for WorldSpace, Inc. from 1997 to 2000 director of marketing for corporate and business at ISI Professional Services from 2000 to 2001 and director of administration at Tanzus Development from 1996 to 1997 and SK&I Architectural Design Group, LLC from 2003 to 2007.- Danica Holley,2016年3月30日以来,她一直担任首席运营官。她的业务开发和管理经验包括在国际环境任职超过18年。她在国际项目管理、政府采购和全球业务交付和初创企业中有丰富经验。从2008年4月15日到现在,她担任Safe Blood International Foundation的执行董事,负责监督在非洲和亚洲的国家卫生计划,包括Ebola反应项目。她担任许多管理职务,包括 WorldSpace, Inc.的战略和公司业务发展董事(从1997年到2000年)、ISI Professional Services的企业和业务营销董事(从2000年到2001年)、Tanzus Development的行政董事(从1996年到1997年)和SK&I Architectural Design Group, LLC的董事(从2003年到2007年)。她拥有10年的跨学科管理复杂的服务交付跨国团队的经验。她持有美国Georgetown大学Edmund Walsh School of Foreign Service的国际法律、政治和组织外交服务学士学位,以及非洲研究证书,并精通阿拉伯语(1994年5月)。她在School for International Training(佛蒙特州伯瑞特波罗和摩洛哥拉巴特)学习国际组织(1993年1月到6月)。她是ICF认证行政领导教练,也是Georgetown大学的Graduate Leadership Coaching Program的校友(2010年9月)。
- Danica Holley has served as a member of the Board since August 2021. Ms. Holley has served as the chief operating officer of Global Medical REIT Inc. since March 2016. Ms. Holley's business development and management experience spans more than 18 years with an emphasis on working in an international environment. She has extensive experience in international program management, government procurement, and global business rollouts and start-ups. As executive director for Safe Blood International Foundation since April 2008 she oversaw national health initiatives in Africa and Asia, including an Ebola response project. Ms. Holley has held management positions as director of strategy, corporate business development for WorldSpace, Inc. from 1997 to 2000 director of marketing for corporate and business at ISI Professional Services from 2000 to 2001 and director of administration at Tanzus Development from 1996 to 1997 and SK&I Architectural Design Group, LLC from 2003 to 2007.
- Allen Webb
Allen Webb,他与2014年12月加入公司。2015年10月以来,他担任证券交易委员会报告和会计技术高级副总裁。他被公司的董事会任命为公司的官员并于2016年6月生效。他在许多行业拥有超过25年证券交易委员会报告和会计技术的经验,包括房地产、医疗、石油和天然气,政府合同和公用事业。从2014年6月到2014年11月,他是一个独立顾问。从2012年12月到2014年5月,他担任Empire Petroleum Partners, LLC(美国最大的和最分散的汽车燃料批发分销商之一)的职务。从2012年12月到2013年5月,他担任Empire财务报告董事。从2013年6月到2014年5月,他担任副总裁和公司财务总监。加入Empire之前在2012年10月和11月时,他曾是独立顾问。从2011年8月到2012年9月,他曾是Versar, Inc.(NYSE:VSR全球项目管理公司,提供联邦、州和当地的客户提供支持)的证券交易委员会报告和会计技术董事。从2011年1月到2011年8月,他曾是独立顾问。出去,他担任Coventry Health Care, Inc.(2013年被Aetna (NYSE:AET)收购)的会计东华寺。他于2008年4月加入Coventry。加入Coventry之前,他曾是Pepco Holdings, Inc.(2016年与Exelon (NYSE:EXC)合并)的财务总监助理。他于1998年8月加入Pepco Holdings。加入Pepco Holdings之前1997年3月,他加入SEC的部门和公司财务的房地产业部门。1990年9月他加入Arthur Andersen,他担任几个REIT的首次公开发行(ipo)活动项目经理。
Allen Webb joined the Company in December 2014 and has served as Senior Vice President, SEC Reporting and Technical Accounting since October 2015. Mr. Webb was appointed by the Company’s Board of Directors as an officer of the Company effective June 8 2016 and was appointed as an officer of our Former Advisor on December 1 2016. Mr. Webb has more than 25 years of experience in SEC reporting and technical accounting within multiple industries, including real estate, healthcare, oil and gas, government contracting, and public utilities. From June 2014 to November 2014 Mr. Webb was an independent consultant. From December 2012 to May 2014 Mr. Webb worked at Empire Petroleum Partners, LLC, one of the largest and most geographically diversified wholesale distributors of motor fuel in the United States. At Empire, Mr. Webb served as Director of Financial Reporting from December 2012 to May 2013 and was promoted to Vice President and Corporate Controller from June 2013 to May 2014. Mr. Webb was an independent consultant during October and November of 2012 before joining Empire. Mr. Webb was the Director of SEC Reporting and Technical Accounting at Versar, Inc. NYSE: VSR, a global project management company providing support to federal, state, and local clients worldwide from August 2011 to September 2012. From January 2011 to August 2011 Mr. Webb was an independent consultant. Prior to this, he served as the Director of Accounting at Coventry Health Care, Inc., which was acquired by Aetna (NYSE: AET) in 2013. Mr. Webb joined Coventry in April 2008. Prior to joining Coventry, Mr. Webb was the Assistant Controller for Pepco Holdings, Inc., which merged with Exelon (NYSE: EXC) in 2016. Mr. Webb joined Pepco Holdings in August 1998. Prior to joining Pepco Holdings, Mr. Webb joined the real estate industry group within the SEC’s Division of Corporation Finance in March 1997 and joined Arthur Andersen in September 1990 where he served as the engagement manager on several REIT initial public offering engagements. Mr. Webb is a Certified Public Accountant in the state of Maryland.- Allen Webb,他与2014年12月加入公司。2015年10月以来,他担任证券交易委员会报告和会计技术高级副总裁。他被公司的董事会任命为公司的官员并于2016年6月生效。他在许多行业拥有超过25年证券交易委员会报告和会计技术的经验,包括房地产、医疗、石油和天然气,政府合同和公用事业。从2014年6月到2014年11月,他是一个独立顾问。从2012年12月到2014年5月,他担任Empire Petroleum Partners, LLC(美国最大的和最分散的汽车燃料批发分销商之一)的职务。从2012年12月到2013年5月,他担任Empire财务报告董事。从2013年6月到2014年5月,他担任副总裁和公司财务总监。加入Empire之前在2012年10月和11月时,他曾是独立顾问。从2011年8月到2012年9月,他曾是Versar, Inc.(NYSE:VSR全球项目管理公司,提供联邦、州和当地的客户提供支持)的证券交易委员会报告和会计技术董事。从2011年1月到2011年8月,他曾是独立顾问。出去,他担任Coventry Health Care, Inc.(2013年被Aetna (NYSE:AET)收购)的会计东华寺。他于2008年4月加入Coventry。加入Coventry之前,他曾是Pepco Holdings, Inc.(2016年与Exelon (NYSE:EXC)合并)的财务总监助理。他于1998年8月加入Pepco Holdings。加入Pepco Holdings之前1997年3月,他加入SEC的部门和公司财务的房地产业部门。1990年9月他加入Arthur Andersen,他担任几个REIT的首次公开发行(ipo)活动项目经理。
- Allen Webb joined the Company in December 2014 and has served as Senior Vice President, SEC Reporting and Technical Accounting since October 2015. Mr. Webb was appointed by the Company’s Board of Directors as an officer of the Company effective June 8 2016 and was appointed as an officer of our Former Advisor on December 1 2016. Mr. Webb has more than 25 years of experience in SEC reporting and technical accounting within multiple industries, including real estate, healthcare, oil and gas, government contracting, and public utilities. From June 2014 to November 2014 Mr. Webb was an independent consultant. From December 2012 to May 2014 Mr. Webb worked at Empire Petroleum Partners, LLC, one of the largest and most geographically diversified wholesale distributors of motor fuel in the United States. At Empire, Mr. Webb served as Director of Financial Reporting from December 2012 to May 2013 and was promoted to Vice President and Corporate Controller from June 2013 to May 2014. Mr. Webb was an independent consultant during October and November of 2012 before joining Empire. Mr. Webb was the Director of SEC Reporting and Technical Accounting at Versar, Inc. NYSE: VSR, a global project management company providing support to federal, state, and local clients worldwide from August 2011 to September 2012. From January 2011 to August 2011 Mr. Webb was an independent consultant. Prior to this, he served as the Director of Accounting at Coventry Health Care, Inc., which was acquired by Aetna (NYSE: AET) in 2013. Mr. Webb joined Coventry in April 2008. Prior to joining Coventry, Mr. Webb was the Assistant Controller for Pepco Holdings, Inc., which merged with Exelon (NYSE: EXC) in 2016. Mr. Webb joined Pepco Holdings in August 1998. Prior to joining Pepco Holdings, Mr. Webb joined the real estate industry group within the SEC’s Division of Corporation Finance in March 1997 and joined Arthur Andersen in September 1990 where he served as the engagement manager on several REIT initial public offering engagements. Mr. Webb is a Certified Public Accountant in the state of Maryland.
- Robert Kiernan
Robert Kiernan于2017年8月加入公司,担任我们的首席财务官兼财务主管。Mr.Kiernan在财务会计、报告和管理方面有超过30年的经验。在加入我们公司之前,基尔南先生从2007年10月开始担任FBR&Co.公司(纳斯达克市场代码:FBRC)的高级副总裁,总监兼首席会计官,并从2003年4月开始担任Arlington Asset InvestmentCorp.公司(阿灵顿资产公司)的类似职务。在加入Arlington Asset之前,Kiernan先生是安永会计师事务所(Ernst&Young)保险业务的高级经理。Kiernan持有Mount St.Mary’;s University会计理学学士学位,成绩优异-1987年,是American Institute of Certified Public Accountants成员。
Robert Kiernan joined the Company as our Chief Financial Officer and Treasurer in August 2017. Mr. Kiernan has more than 30 years of experience in financial accounting, reporting and management. Prior to joining our Company, Mr. Kiernan served as the Senior Vice President, Controller and Chief Accounting Officer of FBR & Co. “FBR” NASDAQ: FBRC commencing in October 2007 and in a similar role for Arlington Asset Investment Corp. (“Arlington Asset” NYSE: AI) commencing in April 2003. Prior to joining Arlington Asset, Mr. Kiernan was a senior manager in the assurance practice at Ernst & Young.Mr. Kiernan holds a Bachelor of Science in Accounting, Mount St. Mary’s University, Cum Laude -1987 and is a member of the American Institute of Certified Public Accountants.- Robert Kiernan于2017年8月加入公司,担任我们的首席财务官兼财务主管。Mr.Kiernan在财务会计、报告和管理方面有超过30年的经验。在加入我们公司之前,基尔南先生从2007年10月开始担任FBR&Co.公司(纳斯达克市场代码:FBRC)的高级副总裁,总监兼首席会计官,并从2003年4月开始担任Arlington Asset InvestmentCorp.公司(阿灵顿资产公司)的类似职务。在加入Arlington Asset之前,Kiernan先生是安永会计师事务所(Ernst&Young)保险业务的高级经理。Kiernan持有Mount St.Mary’;s University会计理学学士学位,成绩优异-1987年,是American Institute of Certified Public Accountants成员。
- Robert Kiernan joined the Company as our Chief Financial Officer and Treasurer in August 2017. Mr. Kiernan has more than 30 years of experience in financial accounting, reporting and management. Prior to joining our Company, Mr. Kiernan served as the Senior Vice President, Controller and Chief Accounting Officer of FBR & Co. “FBR” NASDAQ: FBRC commencing in October 2007 and in a similar role for Arlington Asset Investment Corp. (“Arlington Asset” NYSE: AI) commencing in April 2003. Prior to joining Arlington Asset, Mr. Kiernan was a senior manager in the assurance practice at Ernst & Young.Mr. Kiernan holds a Bachelor of Science in Accounting, Mount St. Mary’s University, Cum Laude -1987 and is a member of the American Institute of Certified Public Accountants.
- Jamie Barber
Jamie Barber于2017年5月加入我们公司,担任总法律顾问兼秘书。在加入我们公司之前,Barber先生于2012年7月至2017年5月担任FBR的副总法律顾问,在那里他协助SEC合规和公司治理事务,并担任FBR&8217;s投资银行业务的首席法律顾问。Barber从2004年8月到2012年6月担任Hunton Andrews Kurth LLP(前身为Hunton&Williams LLP)房地产资本市场副总裁和高级副总裁,在那里,他曾代表Public REITs及其SEC合规要求、公司治理事务和发行股票和债务以及并购交易。从2003年9月到2004年8月,他曾担任Sullivan&Cromwell公司的合伙人,在那里他曾代表发行人和承销商进行股票和债务证券的公开和私人发行。Barber于2003年获得Hofstra University School of Law法律博士学位。他于1999年获得印第安纳大学(Indiana University)的科学、会计和金融学士学位。
Jamie Barber joined our Company as General Counsel and Secretary in May 2017. Prior to joining our Company, from July 2012 to May 2017 Mr. Barber was Associate General Counsel at FBR, where he assisted with SEC compliance and corporate governance matters and was primary counsel for FBR’s investment banking operations. From August 2004 to June 2012 Mr. Barber served as an Associate and Senior Associate - Real Estate Capital Markets at Hunton Andrews Kurth LLP formerly Hunton & Williams LLP, where he represented public REITs in conjunction with their SEC compliance requirements,corporate governance matters and offerings of equity and debt and merger and acquisition transactions. From September 2003 to August 2004 Mr. Barber served as an Associate at Sullivan & Cromwell LLP, where he represented issuers and underwriters in public and private offerings of equity and debt securities.Mr. Barber received his Juris Doctor degree from Hofstra University School of Law in 2003. In 1999 he received his Bachelor of Science, Accounting and Finance, from Indiana University.- Jamie Barber于2017年5月加入我们公司,担任总法律顾问兼秘书。在加入我们公司之前,Barber先生于2012年7月至2017年5月担任FBR的副总法律顾问,在那里他协助SEC合规和公司治理事务,并担任FBR&8217;s投资银行业务的首席法律顾问。Barber从2004年8月到2012年6月担任Hunton Andrews Kurth LLP(前身为Hunton&Williams LLP)房地产资本市场副总裁和高级副总裁,在那里,他曾代表Public REITs及其SEC合规要求、公司治理事务和发行股票和债务以及并购交易。从2003年9月到2004年8月,他曾担任Sullivan&Cromwell公司的合伙人,在那里他曾代表发行人和承销商进行股票和债务证券的公开和私人发行。Barber于2003年获得Hofstra University School of Law法律博士学位。他于1999年获得印第安纳大学(Indiana University)的科学、会计和金融学士学位。
- Jamie Barber joined our Company as General Counsel and Secretary in May 2017. Prior to joining our Company, from July 2012 to May 2017 Mr. Barber was Associate General Counsel at FBR, where he assisted with SEC compliance and corporate governance matters and was primary counsel for FBR’s investment banking operations. From August 2004 to June 2012 Mr. Barber served as an Associate and Senior Associate - Real Estate Capital Markets at Hunton Andrews Kurth LLP formerly Hunton & Williams LLP, where he represented public REITs in conjunction with their SEC compliance requirements,corporate governance matters and offerings of equity and debt and merger and acquisition transactions. From September 2003 to August 2004 Mr. Barber served as an Associate at Sullivan & Cromwell LLP, where he represented issuers and underwriters in public and private offerings of equity and debt securities.Mr. Barber received his Juris Doctor degree from Hofstra University School of Law in 2003. In 1999 he received his Bachelor of Science, Accounting and Finance, from Indiana University.